Placenta Diseases
Conditions
Keywords
3-dimensional ultrasound, ultrasound, placenta, Investigation of placenta in-vivo
Brief summary
In this study is tested the validity of placental vascular indices obtained from placenta ultrasonographic sphere biopsy and entire placenta investigation.
Detailed description
Although, to this date, there have been a number of human placental studies that concerned the evaluation of placental 3 dimensional power Doppler vascularization with the use of VOCAL technique, but there was no one in which placental vasculature has been compared between the sonobiopsy and whole placental volume.
Interventions
Images that contributed to the determination of placental volume and 3-DPD indices were obtained at the time of visit. All 3-D scans ultrasound measurements were performed by a Voluson 730 Expert ultrasound machine equipped with a multifrequency probe (2-5 MHz) to acquire images. Each sample was examined using 3-D rendering mode, in which the colour and gray value information was processed and combined to supply 3-D image. For laterally located placentas, the investigator positioned the transducer on a slight lateral inclination to obtain proper images. Power Doppler window was placed over the placenta to map the vascular tree from basal to chorionic plates. The 3-D static volume box was placed over the entire placenta volume. The sweep angle was set at maximum 70°. Each image was recovered from the disk in succession for processing. During gestation, the investigator recorded one sample from each patient.
The two-dimensional (2-D) transabdominal conventional study provided data about fetal position, biometry, body movements and fetal heart rate as well as placental localization. The factorial default setting 'Obstetrics' was applied in 2-D mode.
Sponsors
Study design
Intervention model description
A prospective cohort study was conducted among normal pregnant women recruited at 11 to 40 gestational weeks. Placental vascularization was evaluated using the 3-DPD-indices (vascularization-index (VI); flow-index (FI); vascularization-flow-index (VFI)) with the application of the sphere-technique or scanned from the entire placenta
Eligibility
Exclusion criteria
* multiple pregnancy, * abnormal (\> 3mm) nuchal translucency from 11+0 to 13+6 weeks of gestation, * the fetal or neonatal structural or chromosomal anomaly, * inadequate localization of the placenta (placenta praevia), * self-reported drugs, alcohol, caffeine or nicotine abuse, * exposed to circulatory medication (oxerutins, calcium dobesilate) * or not signing the consent form. * If the mother suffer from er systemic disease (e.g. diabetes, autoimmune disease, vasculitis, haemophilia, thrombophilia, HIV infection, etc) Inclusion clriteria: * single pregnancy * healthy pregnant women * no anatomical alteration of fetus * no genetical abnormality of fetus
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Neonatal outcome 4; Apgar score | during first day of life | Neonates poor adaptation status (Apgar score (\<7) at 5 minutes) |
| Neonatal outcome 6; delivery complication | during first day of life | Delivery complication ( cesarean section due to fetal distress) |
| Neonatal outcome 7, necessary of intensive care unit | during first week of life | Neonates transfer to neonatal intensive care unit (NICU) |
| Neonatal outcome 5, (umbilical cord pH) | during first day of life | Neonates poor adaptation status (umbilical cord pH \<7.2) |
| Maternal characteristics (BMI) | through study completion, 2 years | The pre-pregnancy body mass index (BMI) registered at the initial visit during prenatal care was calculated as the body weight (kg) per height (m2). |
| Neonatal outcome 1; based on gestational age | during first day of life | The participants were recorded by gestational age et birth |
| Neonatal outcome 2, based on maturation of neonates | during first day of life | Neonates were investigatied by maturation ( gestational age before 36+6 week) (prematurity |
| Neonatal outcome 3, (birth weight of newborns) | during first day of life | Neonates birth weight calculation (gram) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 2D ultrasound investigaiotn of gestation (fetal biometry, placentation) | during prenatal care till the labour | Routine ultrasound examination, based on Guideline of Hungarian Obstetrics and gynecologists (fetal biometry: biparietal diameter, head circumference, abdominal circumference, femur length; investigation of the placenta, place of placentation, Grannum staging) |
Countries
Hungary